Sheldon M. Golden Conference

Golden Conference: Session One

Session One provided clinicians with a comprehensive approach to managing various ocular surface conditions that lead to dry eye. The session began with a multidisciplinary approach to identifying and managing dry eye in patients with autoimmune disease. Participants explored the underlying pathogenesis, diagnosis, and innovative treatment strategies for autoimmune-associated dry eye, along with the optometrist’s role in ensuring the best health outcomes for patients.

The neuropathic component of dry eye was also discussed, with a recap of the latest research and novel therapeutic options. The session covered current management strategies for dry eye using contact lenses, as well as new therapeutic approaches for treating dry eye patients.
[margin space="50"]

[panel title="Sunday, September 29, 2024 (Session One)"]

The Eyes Have It: Multidisciplinary Management of Sjögren’s Disease

Nancy Carteron, MD

Sjögren’s Clinic at Herbert Wertheim School of Optometry & Vision Science

Nancy McNamara, OD, PhD

Professor, Associate Dean for Academic Affairs, & Clinic Chief
Sjögren’s Clinic at Herbert Wertheim School of Optometry & Vision Science

Ava Wu, DDS

Clinical Professor
Sjögren’s Clinic at Herbert Wertheim School of Optometry & Vision Science

–

Recent Research and Discoveries in Neuropathic Dry Eye

Nancy McNamara, OD, PhD

Professor, Associate Dean for Academic Affairs, & Clinic Chief
Sjögren’s Clinic at Herbert Wertheim School of Optometry & Vision Science

–

An Update on Dry Eye Disease and Contact Lenses

Anna Tichenor, OD, PhD

Director of the Dry Eye Clinic, Assistant Professor
Indiana University School of Optometry

–

Updates in Dry Eye Treatments and Therapies

Lisa Hornick, OD, MBA, FAAO

Stanford Ranch Optometry & Sacramento Valley Optometric Association

–

Panel Discussion

Moderated by Pam Satjawatcharaphong, OD, FAAO, FSLS
Assistant Clinical Professor
Herbert Wertheim School of Optometry and Vision Science

[/panel] [margin space="25"] [divider] [margin space="25"]

Golden Conference: Session Two

Session Two centered on the evaporative aspect of dry eye and Meibomian Gland Dysfunction (MGD), covering the latest research and advanced approaches to improve diagnostic and treatment outcomes for patients suffering from this condition.

The session explored the application of intense pulsed light (IPL) therapy as a powerful treatment option for ocular surface disease, the use of artificial intelligence (AI) for deeper insights into MGD, and evidence-based insights from the DREAM clinical trial on the role of omega-3 fatty acids in managing MGD.

[margin space="50"] [panel title="Sunday, September 29, 2024 (Session Two)"]

Harnessing the Power of Intense Pulsed Light Therapy for Ocular Surface Disease

Anna Tichenor, OD, PhD

Director of the Dry Eye Clinic, Assistant Professor
Indiana University School of Optometry

–

What We Learned About MGD From the DREAM Clinical Trial

Penny Asbell, MD, FACS, MBA, FARVO

Barrett G. Haik Endowed Chair for Ophthalmology and Director of the Hamilton Eye Institute
The University of Tennessee Health Science Center

–

Leveraging AI to Better Understand Meibomian Gland Dysfunction

Meng Lin, OD, PhD

Professor of Clinical Optometry & Vision Science
Director, UC Berkeley Clinical Research Center
Herbert Wertheim School of Optometry & Vision Science

–

Panel Discussion

Moderated by Pam Satjawatcharaphong, OD, FAAO, FSLS
Assistant Clinical Professor
Herbert Wertheim School of Optometry and Vision Science

[/panel] [margin space="50"]

2024 Golden Conference Registration Options

[margin space="25"]

[alert icon="exclamation-sign"]REGISTRATION IS NOW CLOSED[/alert] [margin space="50"]

2023 Golden Conference Pricing

Registration for the Golden Conference included 6 hours of COPE-accredited CE, breakfast, and lunch.
[margin space="25"] [accordion header1="Early Registration Pricing (until August 31, 2023)" tab1="

Berkeley Alumni Pricing: $180
Non-Berkeley Alumni Pricing: $210
"] [accordion header1="Standard Registration Pricing (starting September 1, 2023)" tab1="

Berkeley Alumni Pricing: $205
Non-Berkeley Alumni Pricing: $228
"]

[margin space="50"]

Continuing Education Credits

Six CE hours were available for the COPE-accredited Golden Conference program (COPE Activity #126686). This activity met the live, interactive CE coursework requirements of the California State Board of Optometry. For COPE, this activity was considered a ‘Synchronous In-Person’ activity.

[margin space="25"] [panel title="Daily CE Breakdown*"] Sunday, September 24, 2023: COPE Activity #126686

Tackling Parkinson’s Disease With Basic Science (MISC)
COPE Course 85482-SD
1 CE Hour

Parkinson’s Disease for the OD & Panel Discussion (MISC)
COPE Course 85439-NO
1 CE Hour

Glaucoma as a Neurodegenerative Disease (GLC)
COPE Course 85573-GL
1 CE Hour

What We Know About Alzheimer’s Disease (MISC)
COPE Course 86263-NO
1 CE Hour

Alzheimer’s Disease for the OD & Panel Discussion (MISC)
COPE Course 85438-NO
1 CE Hour

An Immunologist’s View of Neurodegenerative Disease (TPA)
COPE Course 86135-NO
0.5 CE Hour

Neurodegenerative Disease & The Eye – Commonalities and Differences: What Can We Learn (GLC)
COPE Course 86262-NO
0.5 CE Hour

*Total CE hours subject to change

[/panel] Please note: Partial attendance of a COPE course did not count towards COPE CE.